- Potential benefitStrengthens supply chain resilience and reduces reliance on foreign PPE suppliers.
- Potential benefitGuarantees government access to specified PPE during declared public health emergencies.
- Potential benefitEncourages higher quality standards by requiring CDC/OSHA compliance and 510(k) clearance.
Domestic SUPPLY Act of 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Oversight and Government Reform, for a period to be subsequently determined by the Speaker, i…
This bill directs HHS, with ASPR and CDC and in coordination with DOD and DHS, to create partnerships with eligible domestic manufacturers to guarantee availability of qualified personal protective equipment (PPE) for public health emergencies. It requires the Secretary to finalize contractual purchasing agreements within one year, defines eligibility criteria for domestic manufacturers (including phased domestic production percentages and majority U.S. ownership), and sets product quality and pricing requirements.
Cost versus security: liberals emphasize safety, conservatives emphasize cost
Relative to its intended legislative type, this bill establishes a substantive policy framework for a domestic PPE production partnership program with a complementary procurement restriction and a congressionally mandated report.
This bill directs HHS, with ASPR and CDC and in coordination with DOD and DHS, to create partnerships with eligible domestic manufacturers to guarantee availability of qualified personal protective equipment (PPE) for public health emergencies.
It requires the Secretary to finalize contractual purchasing agreements within one year, defines eligibility criteria for domestic manufacturers (including phased domestic production percentages and majority U.S. ownership), and sets product quality and pricing requirements.
The bill bars federal, state, and local agencies from using federal funds to buy infectious-disease PPE made outside the United States, with certain statutory exceptions and required documentation for exceptions.
Moderately scoped, bipartisan-appealing subject but contains protectionist mandates and unspecified funding that raise cost, legal, and Senate passage hurdles.
Relative to its intended legislative type, this bill establishes a substantive policy framework for a domestic PPE production partnership program with a complementary procurement restriction and a congressionally mandated report. It defines roles, high‑level mechanisms, eligibility standards, and product qualification criteria, and it anchors provisions to existing statutes and standards.
Cost versus security: liberals emphasize safety, conservatives emphasize cost
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenMay raise procurement costs if domestic prices exceed prior foreign-sourced PPE.
- ManufacturersCould reduce competition and limit supplier diversity by excluding foreign manufacturers.
- CitiesMight strain domestic capacity short-term, causing supply shortages during demand spikes.
Why the argument around this bill splits.
Cost versus security: liberals emphasize safety, conservatives emphasize cost
Generally supportive of strengthening domestic PPE capacity and protecting frontline workers.
Concerned about cost, equitable labor standards, and potential exclusion of global suppliers that could limit access during shortages.
Notes need for clarity on regulatory fit (e.g., NIOSH vs.
Cautiously supportive of bolstering domestic supply chains while seeking cost controls and implementation clarity.
Wants oversight on pricing, realistic timelines, and legally sound exception processes to avoid response gaps.
Mixed reaction: favors domestic manufacturing and national security, but wary of Buy‑American mandates and expanded federal contracting power.
Concerned about market distortions, higher taxpayer costs, and potential corporate favoritism from guaranteed purchases.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Moderately scoped, bipartisan-appealing subject but contains protectionist mandates and unspecified funding that raise cost, legal, and Senate passage hurdles.
- No cost estimate or dedicated funding provided
- Feasibility of 100% domestic supply by 2028
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Cost versus security: liberals emphasize safety, conservatives emphasize cost
Moderately scoped, bipartisan-appealing subject but contains protectionist mandates and unspecified funding that raise cost, legal, and Sen…
Relative to its intended legislative type, this bill establishes a substantive policy framework for a domestic PPE production partnership program with a complementary procurement restriction and a congressionally mandat…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.